{{Drugbox
| IUPAC_name = [1-(4-fluorobenzyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide
| image = FDU-NNE1_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule II
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = 
| legal_NZ = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  
|  ChemSpiderID = 58794744
| smiles            = O=C(C1=CN(CC2=CC=C(F)C=C2)C3=C1C=CC=C3)NC4=C(C=CC=C5)C5=CC=C4
| StdInChI          = 1S/C26H19FN2O/c27-20-14-12-18(13-15-20)16-29-17-23(22-9-3-4-11-25(22)29)26(30)28-24-10-5-7-19-6-1-2-8-21(19)24/h1-15,17H,16H2,(H,28,30)
| StdInChIKey       = XYSIFMHZXZATQO-UHFFFAOYSA-N

<!--Chemical data-->
| C=26 | H=19 | F=1 | N=2 | O=1
| molecular_weight = 394.4 g/mol
}}

'''FDU-NNE1''' (also known as '''FDU-NNEI''' and '''FDU-MN-24''') is an [[indole]]-based [[synthetic cannabinoid]] that is presumed to be a potent [[agonist]] of the [[CB1 receptor|CB<sub>1</sub> receptor]] and has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/17495 | title=FDU-NNEI | publisher=Cayman Chemical | accessdate=23 July 2015}}</ref><ref name="Uchiyama_2015">{{cite journal | url=https://link.springer.com/article/10.1007%2Fs11419-015-0268-7 | title=A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products |author1=Nahoko Uchiyama |author2=Yoshihiko Shimokawa |author3=Ruri Kikura-Hanajiri |author4=Yosuke Demizu |author5=Yukihiro Goda |author6=Takashi Hakamatsuka | journal=Forensic Toxicology |date=February 2015  | doi=10.1007/s11419-015-0268-7 | pmid=26257833 | pmc=4525202 | volume=33 | issue=2 | pages=244–259}}</ref>

==See also==
{{div col|colwidth=30em}}
* [[5F-NNE1]]
* [[5F-PB-22]]
* [[AM-2201]]
* [[QUCHIC|BB-22]]
* [[FUB-JWH-018]]
* [[AB-FUBINACA]]
* [[ADB-FUBINACA]]
* [[AMB-FUBINACA]]
* [[FUB-144]]
* [[FUB-APINACA]]
* [[FUB-NNE1]]
* [[FUB-PB-22]]
* [[MDMB-FUBICA]]
* [[MDMB-FUBINACA]]
* [[NNE1]]
* [[PB-22]]
{{Div col end}}

==References==
{{reflist}}

{{Cannabinoids}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Fluoroarenes]]
[[Category:Indolecarboxamides]]
[[Category:Naphthoylindoles]]


{{cannabinoid-stub}}